HRG and breast carcinoma: It has been reported that Pyk2 is a key effector of EGFR and HER2 signaling in breast cancer, in which Pyk2 is activated by EGF and heregulin (HRG), and positively regulates EGF/HRG-induced cell migration and invasion.